KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Non-Current Deffered Revenue (2017 - 2025)

Moderna (MRNA) has disclosed Non-Current Deffered Revenue for 9 consecutive years, with $153.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Non-Current Deffered Revenue rose 163.79% to $153.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $153.0 million, a 163.79% increase, with the full-year FY2025 number at $153.0 million, up 163.79% from a year prior.
  • Non-Current Deffered Revenue was $153.0 million for Q4 2025 at Moderna, down from $157.0 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $692.0 million in Q2 2023 to a low of $58.0 million in Q1 2024.
  • A 5-year average of $276.8 million and a median of $170.5 million in 2021 define the central range for Non-Current Deffered Revenue.
  • Peak YoY movement for Non-Current Deffered Revenue: skyrocketed 247.46% in 2021, then tumbled 91.38% in 2024.
  • Moderna's Non-Current Deffered Revenue stood at $615.0 million in 2021, then rose by 9.43% to $673.0 million in 2022, then plummeted by 87.67% to $83.0 million in 2023, then plummeted by 30.12% to $58.0 million in 2024, then skyrocketed by 163.79% to $153.0 million in 2025.
  • Per Business Quant, the three most recent readings for MRNA's Non-Current Deffered Revenue are $153.0 million (Q4 2025), $157.0 million (Q3 2025), and $65.0 million (Q2 2025).